Science ❯ Medical Research ❯ Clinical Trials

Drug Development

Regulatory T Cells Oncology Immunotherapy Drugs Schizophrenia Treatments Monoclonal Antibodies Health Outcomes Innovative Therapies FDA Approvals HIV Research NRTIs and Alzheimer's Historical Context Larazotide Autism Research EGFR Mutations Patient Care Health Innovations Neurodevelopmental Disorders Oral Selective Oestrogen Receptor Degraders

Tufts Chemists Unveil Four-Receptor Obesity Drug to Challenge Bariatric Surgery

The novel therapy’s four-receptor approach promises to mirror surgery outcomes with improved tolerability.

Blog Terms of Service Privacy Policy Help Partners About Us

Copyright © 2026 Mina Labs Inc.